The role of hepatitis B vaccine challenge dose in patients with underlying health conditions

We have evaluated the immunological response to Hepatitis B virus (HBV) booster vaccine dose in 129 adults with underlying diseases in comparison with 694 subjects at occupational risk of infection, who have previously completed the primary series and resulted with anti-HBs <10 mIU/mL. After boos...

Full description

Bibliographic Details
Main Authors: L. Sticchi, I. G. Iavarone, P. Durando, A. Di Biagio, I. Schiavetti, F. Murgia, G. Icardi
Format: Article
Language:English
Published: Taylor & Francis Group 2021-02-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2020.1777058

Similar Items